Status | Study |
Recruiting |
Study Name: Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer Condition: Hypopharyngeal Carcinoma Laryngeal Carcinoma Date: 2017-03-29 Interventions: Other: Pharyngo laryngeal MRI Patients will be outgoing a |
Recruiting |
Study Name: A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients Condition: Laryngeal Cancer Hypopharynx Cancer Date: 2017-01-27 Interventions: Device: Modified Trans-Esophageal Prosthesis This device is a biomedical grade silicon voice prosthesis |
Recruiting |
Study Name: Interest of Narrow Band Imaging in Detection of Upper Aerodigestive Cancers Condition: Squamous Cell Carcinoma of Oropharynx Squamous Cell Carcinoma of Hypop Date: 2014-01-10 Interventions: Procedure: WL and NBI For each patient with a suspicion of squamous cell carcinoma of the oropharynx, hy |
Recruiting |
Study Name: Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer Condition: Oropharyngeal Cancer Hypopharyngeal Cancer Date: 2012-01-11 Interventions: Drug: docetaxel and cisplatin |
Completed |
Study Name: Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients Condition: Squamous Cell Carcinoma of Nasopharynx Squamous Cell Carcinoma of Oropharynx Date: 2011-09-20 Interventions: Device: Low Level Laser Therapy- (DMC, São Paulo, Brazil) |
Active, not recruiting |
Study Name: A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab Condition: Oropharyngeal Cancer Hypopharyngeal Cancer Date: 2011-07-26 Interventions: Drug: Cetuximab Arm A: chemoradiation in combination with concurrent cetuximab Arm B: chemoradiation in |
Active, not recruiting |
Study Name: Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) Condition: Hypopharyngeal Cancer Date: 2011-02-21 Interventions: Drug: neoadjuvant docetaxel/cisplatin/fluorouracil |
Completed |
Study Name: Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma Condition: Laryngeal Neoplasms Pharyngeal Neoplasms Date: 2010-07-27 |
Withdrawn |
Study Name: Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence Condition: Head and Neck Cancer Date: 2010-06-10 Interventions: Biological: panitumumab Drug: cisplatin |
Terminated |
Study Name: Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer Condition: Oropharynx Cancer Hypopharynx Cancer Date: 2010-02-05 Interventions: Drug: Homeodent® Two-minu |